Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 4921 AL 4935

Microglia and microglial-based receptors in the pathogenesis and treatment of Alzheimer's disease

Wang Z, Weaver DF.

Int Immunopharmacol. 2022 Sep;110:109070. doi: 10.1016/j.intimp.2022.109070. Epub 2022 Jul 21.

Supramolecular organizing centers at the interface of inflammation and neurodegeneration

Sušjan-Leite P, Ramuta TŽ, Boršić E, Orehek S, Hafner-Bratkovič I.

Front Immunol. 2022 Aug 1;13:940969. doi: 10.3389/fimmu.2022.940969. eCollection 2022.

Cross-tissue analysis of blood and brain epigenome-wide association studies in Alzheimer's disease

C Silva T, Young JI, Zhang L, Gomez L, Schmidt MA, Varma A, Chen XS, Martin ER, Wang L.

Nat Commun. 2022 Aug 18;13(1):4852. doi: 10.1038/s41467-022-32475-x.

Medicine-food herb: Angelica sinensis, a potential therapeutic hope for Alzheimer's disease and related complications

Long Y, Li D, Yu S, Shi A, Deng J, Wen J, Li XQ, Ma Y, Zhang YL, Liu SY, Wan JY, Li N, Yang M, Han L.

Food Funct. 2022 Aug 30;13(17):8783-8803. doi: 10.1039/d2fo01287a.

Deciphering the enigmatic crosstalk between prostate cancer and Alzheimer's disease: A current update on molecular mechanisms and combination therapy

Poddar NK, Agarwal D, Agrawal Y, Wijayasinghe YS, Mukherjee A, Khan S.

Biochim Biophys Acta Mol Basis Dis. 2022 Nov 1;1868(11):166524. doi: 10.1016/j.bbadis.2022.166524. Epub 2022 Aug 17.

When the infectious environment meets the AD brain

Ganz T, Fainstein N, Ben-Hur T.

Mol Neurodegener. 2022 Aug 19;17(1):53. doi: 10.1186/s13024-022-00559-3.

Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights

Sanaie S, Nikanfar S, Kalekhane ZY, Azizi-Zeinalhajlou A, Sadigh-Eteghad S, Araj-Khodaei M, Ayati MH, Andalib S.

Metab Brain Dis. 2023 Jan;38(1):137-162. doi: 10.1007/s11011-022-01059-5. Epub 2022 Aug 20.

Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics

Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH.

Inflammation. 2023 Feb;46(1):1-17. doi: 10.1007/s10753-022-01721-1. Epub 2022 Aug 20.

Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer's Disease

Bhatia S, Singh M, Singh T, Singh V.

Neurochem Res. 2023 Jan;48(1):13-25. doi: 10.1007/s11064-022-03722-w. Epub 2022 Aug 20.

Personalized Prediction of Alzheimer's Disease and Its Treatment Effects by Donepezil: An Individual Participant Data Meta-Analysis of Eight Randomized Controlled Trials

Yoshida K, Seo M, Luo Y, Sahker E, Cipriani A, Leucht S, Iwatsubo T, Efthimiou O, Furukawa TA.

J Alzheimers Dis. 2022;89(4):1143-1157. doi: 10.3233/JAD-220263.

Pharmacological targeting of microglia dynamics in Alzheimer's disease: Preclinical and clinical evidence

Yousefizadeh A, Piccioni G, Saidi A, Triaca V, Mango D, Nisticò R.

Pharmacol Res. 2022 Oct;184:106404. doi: 10.1016/j.phrs.2022.106404. Epub 2022 Aug 18.

Meta-Analysis of the Efficacy and Safety of Olanzapine versus Clozapine when Treating Senile Dementia

Wang Z, Feng Y, Wang Y, Qiu H, Rui Z, Li M, Lv L.

Comput Math Methods Med. 2022 Aug 11;2022:5046761. doi: 10.1155/2022/5046761. eCollection 2022.

Illuminating the Structural Basis of Tau Aggregation by Intramolecular Distance Tracking: A Perspective on Methods

Zeng Z, Fichou Y, Vigers M, Tsay K, Han S.

J Phys Chem B. 2022 Sep 1;126(34):6384-6395. doi: 10.1021/acs.jpcb.2c02022. Epub 2022 Aug 22.

Endosomal trafficking and related genetic underpinnings as a hub in Alzheimer's disease

Limone A, Veneruso I, D'Argenio V, Sarnataro D.

J Cell Physiol. 2022 Oct;237(10):3803-3815. doi: 10.1002/jcp.30864. Epub 2022 Aug 22.

Comparing Medial Temporal Atrophy Between Early-Onset Semantic Dementia and Early-Onset Alzheimer's Disease Using Voxel-Based Morphometry: A Multicenter MRI Study

Kobayashi R, Hayashi H, Kawakatsu S, Shibuya Y, Morioka D, Ohba M, Yoshioka M, Sakamoto K, Kanoto M, Otani K.

Curr Alzheimer Res. 2022;19(7):503-510. doi: 10.2174/1567205019666220820145429.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias